Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.32
+3.9%
$0.27
$0.23
$2.23
$12.29M0.511.06 million shs1.25 million shs
ECIA
Encision
$0.21
+0.5%
$0.33
$0.21
$0.50
$2.51M0.655,290 shs10,100 shs
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$1.48
+0.7%
$1.72
$1.07
$3.00
$13.29M4.59173,174 shs96,845 shs
OSR Holdings, Inc. stock logo
OSRH
OSR
$0.52
+9.1%
$1.03
$0.45
$13.40
$11.11M1.492.19 million shs27.20 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
+8.91%+15.64%+4.25%+32.51%-80.45%
ECIA
Encision
0.00%-3.85%-42.62%-40.00%-40.00%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
+2.80%-0.68%-34.67%+4.26%+18.55%
OSR Holdings, Inc. stock logo
OSRH
OSR
-6.26%-9.81%-54.37%-59.48%+46,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
4.4422 of 5 stars
3.55.00.04.42.00.01.3
ECIA
Encision
N/AN/AN/AN/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
0.3597 of 5 stars
0.02.00.00.02.50.00.6
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
3.00
Buy$5.501,624.68% Upside
ECIA
Encision
0.00
N/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
0.00
N/AN/AN/A
OSR Holdings, Inc. stock logo
OSRH
OSR
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ECIA, OSRH, CODX, and INBS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$1.00M12.24N/AN/A$1.07 per share0.30
ECIA
Encision
$6.55M0.38N/AN/A$0.14 per share1.51
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
$3.05M4.36N/AN/A$0.31 per share4.77
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/A$6.45 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)
ECIA
Encision
-$220K-$0.02N/AN/A-4.34%-16.99%-7.45%N/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$10.57M-$2.05N/A4.23N/A-346.22%-231.13%-108.24%11/6/2025 (Estimated)
OSR Holdings, Inc. stock logo
OSRH
OSR
-$2.41MN/A0.00N/AN/A-12.19%-8.18%N/A

Latest ECIA, OSRH, CODX, and INBS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2025Q4 2025
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
-$0.12-$0.37-$0.25-$0.41$4.30 million$0.84 million
8/14/2025Q2 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million
8/14/2025Q2 2025
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A$0.02N/A$0.02N/A$1.14 million
7/10/2025Q4 2025
ECIA
Encision
N/A-$0.01N/A-$0.01N/A$1.58 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
ECIA
Encision
N/AN/AN/AN/AN/A
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/AN/AN/AN/AN/A
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
4.12
4.23
ECIA
Encision
0.10
1.92
0.72
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
N/A
0.77
0.97
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A
0.18
0.20

Institutional Ownership

CompanyInstitutional Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
ECIA
Encision
8.20%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
32.97%
OSR Holdings, Inc. stock logo
OSRH
OSR
55.30%

Insider Ownership

CompanyInsider Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
8.40%
ECIA
Encision
36.75%
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
1.54%
OSR Holdings, Inc. stock logo
OSRH
OSR
33.67%
CompanyEmployeesShares OutstandingFree FloatOptionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
10038.52 million35.29 millionOptionable
ECIA
Encision
3011.88 million7.51 millionNot Optionable
Intelligent Bio Solutions Inc. stock logo
INBS
Intelligent Bio Solutions
108.98 million8.84 millionNot Optionable
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A21.58 million14.32 millionN/A

Recent News About These Companies

OSR Holdings Amends Note Purchase Agreement

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.32 +0.01 (+3.91%)
Closing price 04:00 PM Eastern
Extended Trading
$0.31 0.00 (-1.54%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Encision OTCMKTS:ECIA

$0.21 +0.00 (+0.48%)
As of 03:57 PM Eastern

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

Intelligent Bio Solutions stock logo

Intelligent Bio Solutions NASDAQ:INBS

$1.48 +0.01 (+0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$1.48 +0.00 (+0.27%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

OSR stock logo

OSR NASDAQ:OSRH

$0.52 +0.04 (+9.09%)
As of 03:59 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.